FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2888896044> ?p ?o ?g. }

• W2888896044 endingPage "462" @default.
• W2888896044 startingPage "462" @default.
• W2888896044 abstract "Glecaprevir (an NS3/4A protease inhibitor) and pibrentasvir (an NS5A inhibitor) are potent and pangenotypic hepatitis C virus (HCV) direct-acting antivirals. This report describes the baseline polymorphisms and treatment-emergent substitutions in NS3 or NS5A detected in samples from HCV genotype 1-infected patients receiving 3-day monotherapy of glecaprevir or pibrentasvir, respectively. None of the NS3 polymorphisms detected in the 47 baseline samples collected prior to glecaprevir monotherapy conferred reduced susceptibility to glecaprevir. The NS3 A156T substitution, which conferred resistance to glecaprevir but had low replication efficiency, emerged in one genotype 1a-infected patient among the 35 patients with available post-baseline sequence data. Baseline NS5A polymorphisms were detected in 12 of 40 patients prior to pibrentasvir monotherapy; most polymorphisms were single-position NS5A amino acid substitutions that did not confer resistance to pibrentasvir. Among the 19 patients with available post-baseline NS5A sequence data, 3 had treatment-emergent NS5A substitutions during pibrentasvir monotherapy. All treatment-emergent NS5A substitutions were linked multiple-position, almost exclusively double-position, substitutions that conferred resistance to pibrentasvir. Replicons engineered with these double-position substitutions had low replication efficiency. In conclusion, resistance-conferring substitutions emerged in a small number of genotype 1-infected patients during glecaprevir or pibrentasvir monotherapy; unlike other NS5A inhibitors, pibrentasvir did not select single-position NS5A substitutions during monotherapy." @default.
• W2888896044 created "2018-09-07" @default.
• W2888896044 creator A5003046890 @default.
• W2888896044 creator A5017869801 @default.
• W2888896044 creator A5019176590 @default.
• W2888896044 creator A5027413766 @default.
• W2888896044 creator A5031450708 @default.
• W2888896044 creator A5035070077 @default.
• W2888896044 creator A5035416018 @default.
• W2888896044 creator A5045180807 @default.
• W2888896044 creator A5047822288 @default.
• W2888896044 creator A5054725734 @default.
• W2888896044 creator A5058318375 @default.
• W2888896044 creator A5063867964 @default.
• W2888896044 creator A5073876921 @default.
• W2888896044 creator A5075322332 @default.
• W2888896044 creator A5078071322 @default.
• W2888896044 creator A5081266398 @default.
• W2888896044 creator A5085966620 @default.
• W2888896044 creator A5086039311 @default.
• W2888896044 date "2018-08-28" @default.
• W2888896044 modified "2023-10-17" @default.
• W2888896044 title "Resistance Analysis of a 3-Day Monotherapy Study with Glecaprevir or Pibrentasvir in Patients with Chronic Hepatitis C Virus Genotype 1 Infection" @default.
• W2888896044 cites W1826210767 @default.
• W2888896044 cites W1967785127 @default.
• W2888896044 cites W1980154502 @default.
• W2888896044 cites W1981385281 @default.
• W2888896044 cites W1983369983 @default.
• W2888896044 cites W1995565071 @default.
• W2888896044 cites W2002927032 @default.
• W2888896044 cites W2003780225 @default.
• W2888896044 cites W2012365423 @default.
• W2888896044 cites W2015763165 @default.
• W2888896044 cites W2040361953 @default.
• W2888896044 cites W2068253682 @default.
• W2888896044 cites W2096347191 @default.
• W2888896044 cites W2100448657 @default.
• W2888896044 cites W2104462601 @default.
• W2888896044 cites W2106172816 @default.
• W2888896044 cites W2132945338 @default.
• W2888896044 cites W2133036275 @default.
• W2888896044 cites W2135249375 @default.
• W2888896044 cites W2141361007 @default.
• W2888896044 cites W2156216120 @default.
• W2888896044 cites W2277092291 @default.
• W2888896044 cites W2279928089 @default.
• W2888896044 cites W2292090508 @default.
• W2888896044 cites W2318156787 @default.
• W2888896044 cites W2461004176 @default.
• W2888896044 cites W2560223644 @default.
• W2888896044 cites W2575880746 @default.
• W2888896044 cites W2588942442 @default.
• W2888896044 cites W2602169852 @default.
• W2888896044 cites W2605116305 @default.
• W2888896044 cites W2605644052 @default.
• W2888896044 cites W2614089632 @default.
• W2888896044 cites W2617734594 @default.
• W2888896044 cites W2617851912 @default.
• W2888896044 cites W2761085897 @default.
• W2888896044 cites W2765116944 @default.
• W2888896044 cites W2765212316 @default.
• W2888896044 cites W2774567315 @default.
• W2888896044 cites W2776863497 @default.
• W2888896044 cites W2788216918 @default.
• W2888896044 cites W2886776749 @default.
• W2888896044 doi "https://doi.org/10.3390/v10090462" @default.
• W2888896044 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6163913" @default.
• W2888896044 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30154359" @default.
• W2888896044 hasPublicationYear "2018" @default.
• W2888896044 type Work @default.
• W2888896044 sameAs 2888896044 @default.
• W2888896044 citedByCount "2" @default.
• W2888896044 countsByYear W28888960442019 @default.
• W2888896044 countsByYear W28888960442020 @default.
• W2888896044 crossrefType "journal-article" @default.
• W2888896044 hasAuthorship W2888896044A5003046890 @default.
• W2888896044 hasAuthorship W2888896044A5017869801 @default.
• W2888896044 hasAuthorship W2888896044A5019176590 @default.
• W2888896044 hasAuthorship W2888896044A5027413766 @default.
• W2888896044 hasAuthorship W2888896044A5031450708 @default.
• W2888896044 hasAuthorship W2888896044A5035070077 @default.
• W2888896044 hasAuthorship W2888896044A5035416018 @default.
• W2888896044 hasAuthorship W2888896044A5045180807 @default.
• W2888896044 hasAuthorship W2888896044A5047822288 @default.
• W2888896044 hasAuthorship W2888896044A5054725734 @default.
• W2888896044 hasAuthorship W2888896044A5058318375 @default.
• W2888896044 hasAuthorship W2888896044A5063867964 @default.
• W2888896044 hasAuthorship W2888896044A5073876921 @default.
• W2888896044 hasAuthorship W2888896044A5075322332 @default.
• W2888896044 hasAuthorship W2888896044A5078071322 @default.
• W2888896044 hasAuthorship W2888896044A5081266398 @default.
• W2888896044 hasAuthorship W2888896044A5085966620 @default.
• W2888896044 hasAuthorship W2888896044A5086039311 @default.
• W2888896044 hasBestOaLocation W28888960441 @default.
• W2888896044 hasConcept C104317684 @default.
• W2888896044 hasConcept C126322002 @default.
• W2888896044 hasConcept C132379496 @default.
• W2888896044 hasConcept C135763542 @default.

• next